Skip to content
Inciteful Med

Getting an Accurate Diagnosis: Labs and Criteria

Last updated:

Systemic lupus erythematosus (SLE) is diagnosed using a specific scoring system. A positive ANA test (titer of at least 1:80) is required first. Then, doctors look for a combination of clinical symptoms and specific blood markers, like Anti-dsDNA, to reach a diagnostic score of 10 or more.

Key Takeaways

  • • A positive ANA test with a titer of at least 1:80 is the required first step for an SLE diagnosis.
  • • Doctors use a 10-point classification system based on symptoms and lab results to confirm systemic lupus.
  • • Key blood markers for lupus include Anti-dsDNA, Anti-Smith, and complement proteins (C3 and C4).
  • • Isolated skin lupus must be distinguished from systemic lupus to avoid unnecessary treatments.
  • • Symptoms only count toward a lupus diagnosis if there is no other more likely explanation for them.

Understanding your lab reports can feel like learning a new language. However, auditing your own labs is one of the most empowering steps you can take. To study and classify Systemic Lupus Erythematosus (SLE), researchers use a specific “scoring system” known as the 2019 EULAR/ACR Classification Criteria [1][2]. While doctors use this point system as a highly reliable framework and guide, these are technically classification criteria rather than strict diagnostic rules. Your doctor will use their clinical judgment to diagnose lupus even if you do not perfectly meet the point threshold.

The “Entry Gate”: The ANA Test

Before anything else, a patient must pass through the “entry gate.” This requires a positive Antinuclear Antibody (ANA) test with a titer of at least 1:80 [1].

  • What it is: Your body produces antibodies to fight viruses. An “antinuclear” antibody mistakenly targets the nucleus (the center) of your own cells [3].
  • What it means: If your ANA is negative or lower than 1:80, a diagnosis of SLE is generally excluded unless there is a very strong clinical reason to suspect it [4][2].

The Point System: Reaching a Score of 10

Once you pass the ANA “gate,” your doctor looks for symptoms and lab markers across different “domains.” Each is worth a certain number of points. To be officially classified with SLE in a research setting, you must have at least 10 points, including at least one clinical symptom [1][5].

  • Clinical Domains: These include things like a butterfly rash (6 points), joint swelling (6 points), or protein in your urine (up to 10 points) [1][2].
  • Immunological Domains: These are your blood markers (see the checklist below).

Your “Completeness Checklist”

To ensure your diagnosis is accurate, your medical file should ideally contain results for the following tests:

Test Name What it Measures Why it Matters in SLE
Anti-dsDNA Antibodies against your DNA Highly specific for lupus; often rises during a “flare” and is linked to kidney health [6][7].
Anti-Smith (Sm) A very specific lupus antibody If this is positive, it is a very strong indicator of SLE, even if other tests are negative [8][9].
Complement (C3 & C4) Immune system proteins These levels drop when lupus is active because your body is “using them up” to create inflammation [10][11].
Antiphospholipid (aPL) Antibodies related to blood clotting These increase the risk of blood clots or pregnancy complications [12][9].
Urinalysis Protein or blood in the urine This is the “gold standard” for checking if lupus is affecting your kidneys [13][11].

Avoiding Diagnostic Pitfalls

A common mistake is mislabeling Cutaneous Lupus (which only affects the skin) as Systemic Lupus (SLE).

  • Isolated Skin Lupus: Conditions like Discoid Lupus (DLE) or Subacute Cutaneous Lupus (SCLE) can cause significant skin issues and a positive ANA, but they may never attack your internal organs [14][15].
  • The Difference: Between 15% and 23% of people with skin lupus might technically meet the “10-point” criteria for SLE, but they often have no internal disease [14]. It is vital to distinguish the two so you are not over-treated with heavy medications you might not need [15][16].

The Attribution Rule: A symptom only counts toward your “10 points” if there is no other more likely explanation [4]. For example, if you have joint pain from an old injury, it shouldn’t be counted as a “lupus point.”

Frequently Asked Questions

What ANA test score is required for a lupus diagnosis?
A positive Antinuclear Antibody (ANA) test with a titer of at least 1:80 is considered the 'entry gate' for a systemic lupus erythematosus diagnosis. If your ANA is lower or negative, SLE is usually ruled out.
How does the 10-point lupus diagnostic criteria work?
Doctors use a scoring system based on clinical symptoms and lab results to classify lupus. To meet the formal criteria for SLE, you need a score of at least 10 points, which must include at least one clinical symptom.
Why are my complement (C3 and C4) levels low?
Low complement levels often indicate active inflammation from lupus. When lupus is active, your body uses up these immune system proteins, causing their levels to drop in your blood tests.
Is skin lupus the same as systemic lupus?
No, cutaneous (skin) lupus, such as discoid lupus, only affects the skin. Systemic lupus erythematosus (SLE) can attack internal organs. It is important to distinguish the two to ensure you receive the appropriate treatment.
What does a positive Anti-Smith (Sm) test mean?
A positive Anti-Smith test is a very strong indicator of systemic lupus. It is highly specific to the disease, meaning if you test positive, it strongly points toward an SLE diagnosis even if other tests are negative.

Questions for Your Doctor

  • • My ANA titer is [insert your titer here]; is it at least 1:80, which is the required 'entry criterion' for a lupus diagnosis?
  • • Since I have a positive ANA, how many points do I have across the clinical and immunological domains of the 2019 EULAR/ACR criteria?
  • • Are my low complement levels (C3 or C4) a sign of active inflammation right now, and how often should we re-test them?
  • • If I only have skin rashes (like DLE or SCLE), are we sure this is Systemic Lupus (SLE) and not just cutaneous lupus?
  • • Do my positive antiphospholipid antibodies mean I need to be on a blood thinner, or are we just monitoring them for now?

Questions for You

  • • Have I looked at my latest lab report? What was the specific 'titer' number listed next to my ANA test (e.g., 1:80, 1:320)?
  • • Besides the labs, what other symptoms have I had in the last few months (e.g., mouth sores, hair loss, or joint pain) that my doctor might not know about?
  • • Have I ever had a blood clot or a history of pregnancy complications that I should mention to my rheumatologist?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus.

    Aringer M, Costenbader K, Daikh D, et al.

    Arthritis & rheumatology (Hoboken, N.J.) 2019; (71(9)):1400-1412 doi:10.1002/art.40930.

    PMID: 31385462
  2. 2

    EULAR/ACR classification criteria for SLE.

    Aringer M

    Seminars in arthritis and rheumatism 2019; (49(3S)):S14-S17 doi:10.1016/j.semarthrit.2019.09.009.

    PMID: 31779843
  3. 3

    Anti-Smith Antibody Positivity Without Lupus in the Setting of Lung Cancer.

    Timlin H, Machireddy K, Shiroky J, et al.

    Cureus 2020; (12(5)):e8298 doi:10.7759/cureus.8298.

    PMID: 32601571
  4. 4

    New lupus criteria: a critical view.

    Aringer M, Johnson SR

    Current opinion in rheumatology 2021; (33(2)):205-210 doi:10.1097/BOR.0000000000000771.

    PMID: 33332888
  5. 5

    Evaluating the Threshold Score for Classification of Systemic Lupus Erythematosus Using the EULAR/ACR Criteria.

    Johnson SR, Diaz Martinez JP, Whittall-Garcia L, et al.

    The Journal of rheumatology 2023; (50(4)):512-518 doi:10.3899/jrheum.220100.

    PMID: 36319012
  6. 6

    Anti-double Stranded DNA Antibodies: Origin, Pathogenicity, and Targeted Therapies.

    Wang X, Xia Y

    Frontiers in immunology 2019; (10()):1667 doi:10.3389/fimmu.2019.01667.

    PMID: 31379858
  7. 7

    Clinical and serological associations of autoantibodies in patients with systemic lupus erythematosus.

    Correa-Rodríguez M, Pocovi-Gerardino G, Callejas-Rubio JL, et al.

    Journal of investigative medicine : the official publication of the American Federation for Clinical Research 2021; (69(8)):1417-1425 doi:10.1136/jim-2021-001887.

    PMID: 34183445
  8. 8

    What is the clinical significance of anti-Sm antibodies in systemic lupus erythematosus? A comparison with anti-dsDNA antibodies and C3.

    Flechsig A, Rose T, Barkhudarova F, et al.

    Clinical and experimental rheumatology 2017; (35(4)):598-606.

    PMID: 28281463
  9. 9

    Clinical and Genetic Risk Factors Associated With the Presence of Lupus Nephritis.

    Shin JM, Kim D, Kwon YC, et al.

    Journal of rheumatic diseases 2021; (28(3)):150-158 doi:10.4078/jrd.2021.28.3.150.

    PMID: 37475996
  10. 10

    An Atypical Initial Manifestation of Systemic Lupus Erythematosus: Lupus Enteritis Accompanied by Intestinal Pseudo-Obstruction and Bilateral Hydronephroureter.

    Naeem F, Noor MU, Batool S, et al.

    Cureus 2023; (15(12)):e50628 doi:10.7759/cureus.50628.

    PMID: 38226118
  11. 11

    Pediatric systemic lupus erythematosus. Retrospective analysis of clinico-laboratory parameters and their association with Systemic Lupus Erythematosus Disease Activity Index score.

    Nazri SKSM, Wong KK, Hamid WZWA

    Saudi medical journal 2018; (39(6)):627-631 doi:10.15537/smj.2018.6.22112.

    PMID: 29915860
  12. 12

    Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus.

    İlgen U, Yayla ME, Ateş A, et al.

    Lupus 2018; (27(4)):665-669 doi:10.1177/0961203317734924.

    PMID: 29050535
  13. 13

    Anti-GAPDH Autoantibody Is Associated with Increased Disease Activity and Intracranial Pressure in Systemic Lupus Erythematosus.

    Sun J, Li X, Zhou H, et al.

    Journal of immunology research 2019; (2019()):7430780 doi:10.1155/2019/7430780.

    PMID: 31049359
  14. 14

    Higher specificity of the new EULAR/ACR 2019 criteria for diagnosing systemic lupus erythematosus in patients with biopsy-proven cutaneous lupus.

    Stec-Polak M, Matyja-Bednarczyk A, Wojas-Pelc A, Pastuszczak M

    Clinical and experimental rheumatology 2021; (39(5)):955-960 doi:10.55563/clinexprheumatol/syxbuz.

    PMID: 32940207
  15. 15

    Autoimmune Skin Conditions: Cutaneous Lupus Erythematosus.

    Foulke G, Helm LA, Clebak KT, Helm M

    FP essentials 2023; (526()):25-36.

    PMID: 36913660
  16. 16

    Subacute Cutaneous Lupus Erythematosus: Clinical Characteristics, Disease Associations, Treatments, and Outcomes in a Series of 90 Patients at Mayo Clinic, 1996-2011.

    Alniemi DT, Gutierrez A, Drage LA, Wetter DA

    Mayo Clinic proceedings 2017; (92(3)):406-414 doi:10.1016/j.mayocp.2016.10.030.

    PMID: 28185656

This page explains SLE diagnostic criteria and lab tests for educational purposes. Your rheumatologist is the best source for interpreting your specific lab results and providing a formal diagnosis.

Stay up to date

Get notified when new research about Systemic lupus erythematosus is published.

No spam. Unsubscribe anytime.